Literature DB >> 9048757

Differential regulation of fast axonally transported proteins during the early response of rat retinal ganglion cells to axotomy.

L Wodarczyk1, V K Merrill, G W Perry.   

Abstract

We have found that the early response of axotomized rat retinal ganglion cells is characterized by the differential regulation of a number of fast axonally transported proteins. The abundance of 23 radiolabeled fast transported proteins was analyzed at 2 and 5 days after axotomy using two-dimensional gel electrophoresis. Corresponding changes in retinal GAP-43 mRNA were measured using northern analysis. Within 2 days of injury, > 40% of the transported proteins analyzed, including GAP-43, showed increased labeling above control levels. Approximately 13% of transported proteins decreased below control levels, whereas the remainder did not change. Five days after axotomy, only GAP-43 and another fast transported protein, C3, continued to sustain measurable increased labeling above control levels; all previously elevated proteins appeared to have been down-regulated by this time, which corresponds to the onset of cell death. These differential changes were accompanied by parallel increases in GAP-43 mRNA. These results suggest that the molecular changes within rat retinal ganglion cells are differentially regulated within two stages subsequent to damage, initial regenerative growth followed by cell death.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048757     DOI: 10.1046/j.1471-4159.1997.68031114.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  2 in total

1.  Lens injury stimulates axon regeneration in the mature rat optic nerve.

Authors:  S Leon; Y Yin; J Nguyen; N Irwin; L I Benowitz
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

2.  The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats.

Authors:  R Lucius; S Gallinat; P Rosenstiel; T Herdegen; J Sievers; T Unger
Journal:  J Exp Med       Date:  1998-08-17       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.